###begin article-title 0
###xml 27 42 <span type="species:ncbi:8030">Atlantic salmon</span>
Constitutive expression of Atlantic salmon Mx1 protein in CHSE-214 cells confers resistance to Infectious Salmon Anaemia virus
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 212 221 212 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Isavirus </italic>
###xml 239 255 239 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Orthomyxoviridae</italic>
###xml 88 103 <span type="species:ncbi:8030">Atlantic salmon</span>
###xml 134 138 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 471 485 <span type="species:ncbi:74940">Chinook salmon</span>
###xml 536 551 <span type="species:ncbi:8030">Atlantic salmon</span>
###xml 629 633 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 796 800 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 932 936 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 1222 1226 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 1277 1281 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
Infectious salmon anaemia (ISA) is a highly fatal viral disease affecting marine-farmed Atlantic salmon which is caused by ISA virus (ISAV), a fish orthomyxovirus that has recently been assigned to the new genus Isavirus within the family Orthomyxoviridae. Mx proteins are among the interferon (IFN)-induced proteins responsible for the development of an antiviral state in vertebrate cells. We used real-time reverse transcription-polymerase chain reaction (RT-PCR) and Chinook salmon embryo (CHSE-214) cells constitutively expressing Atlantic salmon Mx1 protein (ASMx1) to examine the antiviral properties of ASMx1 against two ISAV strains, NBISA01 and HKS-36, having phenotypically different growth properties (cytopathic vs non-cytopathic) in the CHSE-214 cell line. We present evidence that ISAV is sensitive to ASMx1. CHSE-214 cells constitutively expressing ASMx1 showed increased resistance to infection with the cytopathic ISAV strain NBISA01, manifested as delayed development of cytopathic effects (CPE) and significant reduction in the severity of CPE, as well as a 10-fold reduction in virus yield. However, by real-time RT-PCR we observed no significant difference in the mean threshold cycle (Ct) values of ISAV RNA levels, suggesting that the ASMx1 activity on ISAV occurs at the post-transcription steps of virus replication, possibly in the cytoplasm.
###end p 2
###begin title 3
Findings
###end title 3
###begin p 4
###xml 200 209 200 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Isavirus </italic>
###xml 227 244 227 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Orthomyxoviridae </italic>
###xml 245 246 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 491 492 491 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 516 525 516 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Isavirus </italic>
###xml 659 660 659 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 706 707 706 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 888 889 888 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1122 1123 1122 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1124 1125 1124 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 39 43 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 109 124 <span type="species:ncbi:8030">Atlantic salmon</span>
###xml 921 925 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 1065 1069 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
Infectious salmon anaemia (ISA) virus (ISAV), the causative agent of a highly fatal disease of marine-farmed Atlantic salmon, is a fish orthomyxovirus that has recently been assigned to the new genus Isavirus within the family Orthomyxoviridae [1]. The disease has caused severe economic losses to the salmon-farming industry in several countries in the northern hemisphere, and confirmed positive diagnostic results for ISA are reportable to the "Office International des Epizooties", OIE [2]. Viruses in the genus Isavirus are enveloped particles of 90-140 nm diameter with surface projections consisting of a combined haemagglutinin-esterase (HE) protein [3] and a separate putative fusion (F) protein [4]. The genome is composed of eight segments of linear, single-stranded negative sense RNA ranging in length from 1.0 to 2.4 kb with a total molecular size of approximately 14.3 kb [5]. Sequence analysis of several ISAV isolates on the eight segments consistently reveals two genotypes, one European and one North American. The gene-coding assignments of the ISAV genome differ from those of other orthomyxoviruses [2,4].
###end p 4
###begin p 5
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 436 437 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 16 20 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 286 290 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
Some strains of ISAV can replicate and cause CPE in the CHSE-214 cell line while others do not replicate in this cell line at all [6,7]. The molecular basis for this phenotypic difference is not clearly known. Although there is a strong geographical correlation in that practically all ISAV isolates of the European genotype do not cause CPE in the CHSE cell line, this phenotype is not related to sequence variation in the HE protein [8].
###end p 5
###begin p 6
###xml 337 338 337 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 790 792 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 793 795 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 937 939 930 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 940 942 933 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1011 1013 1004 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1014 1016 1007 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1028 1037 1021 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in-vitro </italic>
###xml 1170 1183 1163 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Birnaviridae </italic>
###xml 1245 1247 1238 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1248 1250 1241 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 234 238 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 308 312 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 1094 1130 <span type="species:ncbi:11002">infectious pancreatic necrosis virus</span>
###xml 1132 1136 <span type="species:ncbi:11002?0.9770992366412213">IPNV</span>
###xml 1239 1243 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 1294 1298 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 1303 1307 <span type="species:ncbi:11002?0.9770992366412213">IPNV</span>
###xml 1371 1386 <span type="species:ncbi:8030">Atlantic salmon</span>
###xml 1426 1430 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 1542 1546 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 1583 1587 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
In general, fish viral diseases are difficult to control due to the high susceptibility of fish at an early age, and insufficient knowledge of pathogenesis of virus infections. In this context, we are studying the mechanisms by which ISAV interacts with its host, including the identification of markers for ISAV virulence. Vertebrates [9], including fish [10], mount an early strong innate immune response against virus infections, characterized by the induction and secretion of cytokines, such as type I interferons (IFN-alpha/beta) that mediate an antiviral state. Secreted IFNs signal through a common receptor activating a JAK/STAT signaling pathway which leads to the transcriptional upregulation of numerous IFN-stimulated genes (ISGs), a number of which encode antiviral proteins [10-12]. The induced antiviral proteins include dsRNA-dependent protein kinase R (PKR), 2',5'-oligoadenylate synthetase (OAS), and the Mx proteins [10,12]. Viruses have evolved mechanisms to subvert the host IFN response [12,13]. Previous in-vitro studies revealed that ASMx1 inhibited the replication of infectious pancreatic necrosis virus (IPNV), a dsRNA virus belonging to the Birnaviridae family, but it did not appear to inhibit replication of ISAV [14,15]. It was concluded from those results that ISAV and IPNV have developed different strategies to avoid the IFN-system of Atlantic salmon. Thus, we were interested in analyzing ISAV strains having phenotypically different growth properties in the CHSE-214 cell line to gain further insight in ISAV virulence. We present evidence that ISAV is sensitive to the antiviral activity of ASMx1.
###end p 6
###begin p 7
###xml 177 178 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 364 365 364 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 366 367 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1128 1133 1128 1133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8.16 </sup>
###xml 1137 1139 1137 1139 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 1162 1166 1162 1166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7.16</sup>
###xml 1170 1172 1170 1172 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 1221 1223 1221 1223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 1466 1467 1466 1467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1721 1722 1721 1722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 18 22 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 436 440 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 1012 1016 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
The following two ISAV isolates were selected for use in this study: NBISA01 and HKS-36. The growth properties of the isolates in CHSE-214 cells have been previously described [6]. NBISA01 is CPE-positive whereas HKS-36 is CPE-negative in CHSE-214 cells. For use, the viruses were propagated and titrated in CHSE-214 cells and/or TO cells as previously described [6,8]. To demonstrate the effects of ASMx1 on the replication of the two ISAV strains, we compared the cytopathogenicity and virus yields of the viruses in normal CHSE-214 cells and in cells constitutively expressing ASMx1. The CHSE-214 cells constitutively expressing ASMx1 [15] were a kind gift from Dr. Borre Robertsen, Norwegian College of Fishery Science, University of Tromso, Norway. These cells were grown in presence of 0.5 mg/ml zeocine (Invitrogen Life Technologies) to maintain expression of the transfected genes (Dr. Borre Robertsen, personal communication). Virus stocks were prepared from TO cell cultures infected with the selected ISAV isolates which were harvested when CPE was complete; usually 7-9 days post inoculation (dpi). They contained 108.16 TCID50/ml for NBISA01, and 107.16TCID50/ml for HKS-36. CHSE-214 cell monolayers in 25 cm2 tissue culture flasks, each inoculated with 1 ml of virus, were monitored daily for CPE and were harvested 14 dpi. Viral titers of the harvests were determined on normal CHSE-214 cells in 48-well tissue culture plates as previously described [6]. A significant delay in development of CPE and a reduction in the severity of CPE, as well as a 10-fold reduction in virus yield were observed for NBISA01 grown in CHSE-214 cells constitutively expressing ASMx1 compared to normal CHSE-214 cells (Table 1). No CPE was seen with HKS-36 in both types of CHSE-214 cells.
###end p 7
###begin p 8
###xml 14 18 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
Inhibition of ISAV NBISA01 by AsMx1 in CHSE-214 cells.
###end p 8
###begin p 9
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
1CHSE-214 cells: Normal CHSE-214 cells and CHSE-214 cells constitutively expressing ASMx1.
###end p 9
###begin p 10
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
2CPE development denotes time from first appearance to complete CPE in days post inoculation; * indicates incomplete CPE development by 14 days post inoculation.
###end p 10
###begin p 11
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
3CPE severity was scored from 1+ to 5+: Complete CPE was scored 5+; Incomplete CPE scored 1+ to 4+).
###end p 11
###begin p 12
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 35 37 35 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
4Virus titers are expressed as TCID50/ml.
###end p 12
###begin p 13
###xml 251 252 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 562 563 562 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 235 239 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 378 382 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 654 658 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
In an attempt to assess the effects of ASMx1 on the viral mRNA levels, we used real-time RT-PCR in the LightCycler with RNA Amplification Kit SYBR Green I (Roche Applied Science) and PCR primers FA-3/RA-3 targeting a 220-bp product on ISAV segment 8 [7]. This assay has been shown to be 100 times more sensitive than the conventional one-tube RT-PCR assay, and to differentiate ISAV isolates into three CHSE phenotypes (replicating cytopathic, replicating non-cytopathic, and non-replicating) based on their ability to replicate and cause CPE in CHSE-214 cells [7]. Total RNA was extracted from 300 mul of cell culture supernatants of the uninfected and ISAV-infected tissue cultures harvested at 14 dpi by using TRIZOL reagent (Invitrogen Life Technologies). The RNA pellet was dissolved in 10 mul of RNase free water and 1 mul was used in real-time RT-PCR. The assay was performed on three replicates of each virus sample. The thermal conditions were one cycle of reverse transcription at 55degreesC for 30 min, pre-denaturation at 95degreesC for 30 s followed by 50 cycles of 95degreesC for 5s, 59degreesC for 10s, 72degreesC for 10s, and data acquisition at 80degreesC for 2s. Melting curve analysis was performed from 70degreesC to 95degreesC in 0.1degreesC/s increments to assess the specificity of the RT-PCR products. The quantitative (Ct values) and melting curve data were analyzed using LightCycler software version 3.5 (Roche Applied Science). The real-time amplification reaction products were also resolved by 1% agarose gel electrophoresis in 0.5 x TBE buffer and visualized by staining with ethidium bromide and photographed under 304 nm UV light.
###end p 13
###begin p 14
###xml 47 48 47 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 49 50 49 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 51 52 51 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 153 155 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 232 234 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2G</xref>
###xml 317 319 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 397 399 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2J</xref>
###xml 550 551 542 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 551 553 543 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m </italic>
###xml 551 553 543 545 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>m </italic></sub>
###xml 699 704 683 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B, E</xref>
###xml 766 771 750 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2H, K</xref>
###xml 838 843 822 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C, F</xref>
###xml 853 858 837 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2I, L</xref>
###xml 1149 1154 1125 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3N, Q</xref>
###xml 1179 1181 1149 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3T</xref>
###xml 1340 1348 1310 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3O, R, U</xref>
###xml 1663 1664 1633 1634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1690 1692 1660 1662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1702 1704 1672 1674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2G</xref>
###xml 2199 2201 2169 2171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 2592 2594 2562 2564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 75 79 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 560 564 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 1514 1518 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 2019 2023 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 2089 2094 <span type="species:ncbi:9606">human</span>
###xml 2099 2104 <span type="species:ncbi:10090">mouse</span>
###xml 2259 2264 <span type="species:ncbi:10090">mouse</span>
###xml 2393 2398 <span type="species:ncbi:9606">human</span>
###xml 2641 2645 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 2671 2676 <span type="species:ncbi:9606">human</span>
###xml 2692 2709 <span type="species:ncbi:11320">influenza A virus</span>
The real-time RT-PCR data are shown in Figures 1,2,3. The mean Ct value of ISAV RNA levels for NBISA01 was 17.39 +/- 0.24 in normal CHSE-214 cells (Fig. 1A) and 17.62 +/- 0.08 in CHSE-214 cells constitutively expressing ASMx1 (Fig. 2G). For HKS-36, the mean Ct value was 22.94 +/- 0.08 in normal CHSE-214 cells (Fig. 1D) and 21.08 +/- 0.003 in CHSE-214 cells constitutively expressing ASMx1 (Fig. 2J). For each virus strain, there was no significant difference in the Ct values of both types of CHSE-214 cells. Melting curve analysis showed that the Tm of the ISAV templates was 82.5 +/- 0.03degreesC and occurred as a single amplicon peak for both NBISA01 and HKS-36 in normal CHSE-214 cells (Fig. 1B, E) and in CHSE-214 cells constitutively expressing ASMx1 (Fig. 2H, K). All these amplicons had one band of 220 bp on agarose gel (Fig. 1C, F and Fig. 2I, L), indicating virus-specific amplification and uniform virus populations in the individual virus samples. The melting curve analyses of amplification products of uninfected CHSE-214 cells and water control indicated the presence of primer dimers having values of 77.4 +/- 0.01degreesC (Fig. 3N, Q) and 78.1degreesC (Fig. 3T), respectively. No viral amplicon-specific melting peaks were observed in these samples. The absence of the 220 bp band on agarose gel in these samples (Fig. 3O, R, U) further confirmed the validity of melting curve analyses of these samples. Thus, by real-time RT-PCR we were not able to detect any effect of the ASMx1 activity on ISAV replication for both NBISA01 and HKS-36. In case of NBISA01, this indicated to us that there was no correlation between the virus yields (Table 1) and the Ct values (Fig. 1A and Fig. 2G). This would be expected since the real-time RT-PCR detected both mRNA and viral genomic RNA and was not indicative of infectious virus. Moreover, RNA detected by real-time RT-PCR could be from infectious as well as non-infectious viral progeny. These observations allow us to speculate that the ASMx1 activity on ISAV occurs at the post-transcription steps of virus replication. The human and mouse Mx proteins are known to inhibit different steps of the influenza virus multiplication cycle [16] which is dictated by their intracellular locations. The mouse Mx1 protein accumulates in the nucleus and interferes with primary transcription of influenza virus in the nucleus, whereas the human MxA protein which is localized in the cytoplasm inhibits a subsequent step that presumably takes place in the cytoplasm of infected cells. ASMx1 has been reported to localize in the cytoplasm [15]. Thus in this context, the ASMx1 activity on ISAV may resemble that of the human MxA protein on influenza A virus.
###end p 14
###begin p 15
###xml 0 205 0 205 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Amplification, melting curve, and agarose gel electrophoresis of RT-PCR targeting a 220-bp product on ISAV segment 8 using total RNA from ISAV-infected normal CHSE-214 cells: NBISA01 (A-C) and HKS-36 (D-F)</bold>
###xml 294 296 294 296 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C </bold>
###xml 300 302 300 302 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F </bold>
###xml 102 106 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 138 142 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
Amplification, melting curve, and agarose gel electrophoresis of RT-PCR targeting a 220-bp product on ISAV segment 8 using total RNA from ISAV-infected normal CHSE-214 cells: NBISA01 (A-C) and HKS-36 (D-F). Total RNA was subjected to real-time RT-PCR with 50 cycle amplification. The arrows in C and F indicate the expected band of 220 bp on agarose gel.
###end p 15
###begin p 16
###xml 0 237 0 237 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Amplification, melting curve, and agarose gel electrophoresis of RT-PCR targeting a 220-bp product on ISAV segment 8 using total RNA from ISAV-infected normal CHSE-214 cells constitutively expressing ASMx1: NBISA01 (G-I) and HKS-36 (J-L)</bold>
###xml 326 328 326 328 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I </bold>
###xml 332 334 332 334 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L </bold>
###xml 102 106 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 138 142 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
Amplification, melting curve, and agarose gel electrophoresis of RT-PCR targeting a 220-bp product on ISAV segment 8 using total RNA from ISAV-infected normal CHSE-214 cells constitutively expressing ASMx1: NBISA01 (G-I) and HKS-36 (J-L). Total RNA was subjected to real-time RT-PCR with 50 cycle amplification. The arrows in I and L indicate the expected band of 220 bp on agarose gel.
###end p 16
###begin p 17
###xml 0 273 0 273 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Amplification, melting curve, and agarose gel electrophoresis of RT-PCR targeting a 220-bp product on ISAV segment 8 using total RNA from uninfected controls: normal CHSE-214 cells (M-O), CHSE-214 cells constitutively expressing ASMx1 (P-R) and the water only control (S-U)</bold>
###xml 361 362 361 362 <bold xmlns:xlink="http://www.w3.org/1999/xlink">O</bold>
###xml 364 366 364 366 <bold xmlns:xlink="http://www.w3.org/1999/xlink">R </bold>
###xml 370 372 370 372 <bold xmlns:xlink="http://www.w3.org/1999/xlink">U </bold>
###xml 402 403 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 102 106 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
Amplification, melting curve, and agarose gel electrophoresis of RT-PCR targeting a 220-bp product on ISAV segment 8 using total RNA from uninfected controls: normal CHSE-214 cells (M-O), CHSE-214 cells constitutively expressing ASMx1 (P-R) and the water only control (S-U). Samples were subjected to real-time RT-PCR with 50 cycle amplification. The arrows in O, R and U represent DNA markers in lane M; note the absence of the 220 bp-band on these agarose gels.
###end p 17
###begin p 18
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 500 502 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 515 517 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 652 654 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 732 734 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 789 791 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1271 1272 1264 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1345 1346 1338 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1414 1416 1407 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 86 90 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 329 346 <span type="species:ncbi:11320">Influenza A virus</span>
###xml 587 604 <span type="species:ncbi:11520">Influenza B virus</span>
###xml 737 750 <span type="species:ncbi:11569">Thogoto virus</span>
###xml 824 828 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 993 997 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 1057 1061 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 1082 1099 <span type="species:ncbi:11320">influenza A virus</span>
###xml 1530 1534 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 1606 1610 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 1630 1645 <span type="species:ncbi:8030">Atlantic salmon</span>
###xml 1679 1683 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
To our knowledge these are the first studies demonstrating that ASMx1 interferes with ISAV replication and suggest that this interference occurs after viral mRNA synthesis. Orthomyxoviruses are known to be sensitive to the antiviral action of type I IFN, and have evolved viral IFN antagonists to suppress IFN induction [17-19]. Influenza A virus NS1 protein binds dsRNA [20] and prevents activation of PKR [21] and OAS [22]. Additionally, the NS1 protein is able to prevent activation of NFkappa-B [23] and IRF-3 [24] which are necessary for IFN-beta synthesis in virus infected cells. Influenza B virus NS1 protein also inhibits activation of IRF-3 [19], and the activity of ISG15, one of the major type I IFN inducible proteins [25]. Thogoto virus protein ML suppresses IRF-3 function [26]. It is therefore expected that ISAV also encodes protein(s) with IFN antagonistic properties, giving the virus an advantage in its fight against the antiviral host response to infection. The complete ISAV protein profile has not yet been definitively established. ISAV segment 8, like its influenza A virus counterpart, has been shown to encode two proteins; one open reading frame (ORF) was shown to encode a major structural protein corresponding to the virus matrix protein [3], and the other ORF is considered to encode the non-structural protein [2] albeit with no sequence similarity to the influenza NS1 proteins [27]. It would be interesting to see if IFN and ISGs knockdowns would enhance the growth and/or cytopathogenicity of ISAV. This would provide further insight into the exact mechanisms by which ISAV interacts with the Atlantic salmon IFN system with implications for ISAV virulence.
###end p 18
###begin title 19
List of abbreviations
###end title 19
###begin p 20
###xml 0 31 <span type="species:ncbi:55987">Infectious salmon anaemia virus</span>
###xml 33 37 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
###xml 40 55 <span type="species:ncbi:8030">Atlantic salmon</span>
Infectious salmon anaemia virus (ISAV), Atlantic salmon Mx1 protein (ASMx1), cytopathic effect (CPE), Tris borate EDTA (TBE).
###end p 20
###begin title 21
Competing interests
###end title 21
###begin p 22
The author(s) declare that they have no competing interests.
###end p 22
###begin title 23
Authors' contributions
###end title 23
###begin p 24
MJTK conducted all the experiments and wrote the manuscript. KM assisted with running the real-time RT-PCR assays and with writing the manuscript. FSBK conceived the study, coordinated the research efforts and edited the paper. All three co-authors read and approved the final manuscript.
###end p 24
###begin title 25
Acknowledgements
###end title 25
###begin p 26
We kindly thank Dr. Borre Robertsen for the CHSE-214 cells constitutively expressing ASMx1. This work was supported by Natural Sciences and Engineering Research Council (NSERC) of Canada Strategic Grants and an NSERC Discovery Grant.
###end p 26
###begin article-title 27
Infectious Salmon Anaemia Virus
###end article-title 27
###begin article-title 28
###xml 0 31 <span type="species:ncbi:55987">Infectious salmon anaemia virus</span>
Infectious salmon anaemia virus: causative agent, pathogenesis and immunity
###end article-title 28
###begin article-title 29
###xml 67 98 <span type="species:ncbi:55987">infectious salmon anaemia virus</span>
Identification andcharacterization of viral structural proteins of infectious salmon anaemia virus
###end article-title 29
###begin article-title 30
###xml 53 84 <span type="species:ncbi:55987">infectious salmon anaemia virus</span>
###xml 86 90 <span type="species:ncbi:55987?0.8933333333333333">ISAV</span>
Characterization of major structural proteins of the infectious salmon anaemia virus (ISAV)
###end article-title 30
###begin article-title 31
###xml 24 55 <span type="species:ncbi:55987">infectious salmon anaemia virus</span>
Genomic organization of infectious salmon anaemia virus
###end article-title 31
###begin article-title 32
###xml 10 41 <span type="species:ncbi:55987">infectious salmon anaemia virus</span>
Growth of infectious salmon anaemia virus in CHSE-214 cells and evidence for phenotypic differences between virus strains
###end article-title 32
###begin article-title 33
###xml 13 44 <span type="species:ncbi:55987">infectious salmon anaemia virus</span>
Detection of infectious salmon anaemia virus by real-time RT-PCR
###end article-title 33
###begin article-title 34
###xml 38 69 <span type="species:ncbi:55987">infectious salmon anaemia virus</span>
Antigenic variation among isolates of infectious salmon anaemia virus correlates with genetic variation of the viral haemagglutinin gene
###end article-title 34
###begin article-title 35
Antiviral actions of interferons
###end article-title 35
###begin article-title 36
###xml 25 37 <span type="species:ncbi:70862">teleost fish</span>
The interferon system of teleost fish
###end article-title 36
###begin article-title 37
Interferons: cell signalling, immune modulation, antiviral responses and virus countermeasures
###end article-title 37
###begin article-title 38
How cells respond to interferons
###end article-title 38
###begin article-title 39
Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses
###end article-title 39
###begin article-title 40
###xml 74 89 <span type="species:ncbi:8030">Atlantic salmon</span>
###xml 104 135 <span type="species:ncbi:55987">infectious salmon anaemia virus</span>
###xml 140 176 <span type="species:ncbi:11002">infectious pancreatic necrosis virus</span>
Effect of double-stranded RNA and interferon on the antiviral activity of Atlantic salmon cells against infectious salmon anaemia virus and infectious pancreatic necrosis virus
###end article-title 40
###begin article-title 41
###xml 14 50 <span type="species:ncbi:11002">infectious pancreatic necrosis virus</span>
###xml 66 81 <span type="species:ncbi:8030">Atlantic salmon</span>
Inhibition of infectious pancreatic necrosis virus replication by Atlantic salmon Mx1 protein
###end article-title 41
###begin article-title 42
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 10 15 <span type="species:ncbi:10090">mouse</span>
Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle
###end article-title 42
###begin article-title 43
###xml 0 17 <span type="species:ncbi:11320">Influenza A virus</span>
Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems
###end article-title 43
###begin article-title 44
###xml 22 36 22 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Thogoto virus </italic>
###xml 22 35 <span type="species:ncbi:11569">Thogoto virus</span>
Novel gene product of Thogoto virus segment 6 codes for an interferon antagonist
###end article-title 44
###begin article-title 45
###xml 52 69 <span type="species:ncbi:11520">influenza B virus</span>
The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation
###end article-title 45
###begin article-title 46
###xml 11 28 <span type="species:ncbi:11320">influenza A virus</span>
Binding of influenza A virus NS1 protein to dsRNA
###end article-title 46
###begin article-title 47
Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication
###end article-title 47
###begin article-title 48
Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the Eif-2 translation initiation factor
###end article-title 48
###begin article-title 49
###xml 0 17 <span type="species:ncbi:11320">Influenza A virus</span>
Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of Alpha/Beta interferon
###end article-title 49
###begin article-title 50
###xml 65 82 <span type="species:ncbi:11320">influenza A virus</span>
Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein
###end article-title 50
###begin article-title 51
###xml 0 17 <span type="species:ncbi:11520">Influenza B virus</span>
Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein
###end article-title 51
###begin article-title 52
###xml 0 13 <span type="species:ncbi:11569">Thogoto virus</span>
Thogoto virus ML protein suppresses IRF3 function
###end article-title 52
###begin article-title 53
###xml 92 105 92 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Salmo salar L</italic>
###xml 75 90 <span type="species:ncbi:8030">Atlantic salmon</span>
###xml 92 103 <span type="species:ncbi:8030">Salmo salar</span>
Genomic characterization of the virus causing infectious salmon anaemia in Atlantic salmon (Salmo salar L): an orthomyxo-like virus in a teleost
###end article-title 53

